Volastra Therapeutics

View the org chart displaying its 10 main executives

Most searched biographies at Volastra Therapeutics

• Charles Hugh-Jones, Chief Executive Officer
• David Nicholson, Director
• Jianmin Mao, Senior Vice President, Chemistry Manufacturing and Co...

Popular executive movements at Volastra Therapeutics

• David Nicholson has joined the company as Director  (posted on November 7 2023).

Create your alert
to follow the executive moves at Volastra Therapeutics.

Volastra Therapeutics has 2,292 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Lycia Therapeutics has just announced a $107 Million fundraising (posted on May 15 2024).
• Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on May 13 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Volastra Therapeutics

• News - Volastra
• Press Releases - Volastra

Social media about Volastra Therapeutics

• Volastra Therapeutics on Wikipedia, Google News & Yahoo Finance
• Volastra Therapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Charles Hugh-Jones

Call Volastra Therapeutics at +1 646...

View the org chart

Register to receive your alert

Report an error